STOCK TITAN

Camden Ppty Tr Financials

CPT
Source SEC Filings (10-K/10-Q) Updated May 1, 2026 Currency USD FYE December

This page shows Camden Ppty Tr (CPT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CPT FY2025

Camden’s operating model is cash-generative but capital-hungry, with distributions and buybacks absorbing most of internally produced funds.

Operating cash flow kept rising to $827M in FY2025 even as cash on hand shrank to $25.2M, which means the business is not stockpiling liquidity; it is continually recycling cash into asset investment, shareholder distributions, and other capital uses. That pattern matters because long-term debt moved up while equity moved down over the last two years, the signature of an asset-heavy funding model where cash is produced steadily but quickly re-allocated.

Earnings understate the cash engine: FY2025 depreciation was $611M against net income of $384M, which helps explain why operating cash flow stays healthier than bottom-line profit alone would suggest. That makes reported profit a less complete guide to operating capacity than cash generation.

Borrowing costs are climbing with leverage: interest expense reached $138M in FY2025 versus $97.3M in FY2021, so more recurring cash generation is committed before any capital returns are made. Dividends still absorbed about 55.8% of FY2025 operating cash flow, leaving year-end cash at just $25.2M rather than building a large cushion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 35 / 100
Financial Profile 35/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Camden Ppty Tr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
100

Camden Ppty Tr's revenue surged 81.7% year-over-year to $13.0M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage
84

Camden Ppty Tr carries a low D/E ratio of 0.89, meaning only $0.89 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.

Returns
27

Camden Ppty Tr generates a 8.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 27/100. This is up from 3.5% the prior year.

Piotroski F-Score Strong
7/9

Camden Ppty Tr passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
2.15x

For every $1 of reported earnings, Camden Ppty Tr generates $2.15 in operating cash flow ($826.6M OCF vs $384.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$13.0M
YoY+81.7%
5Y CAGR+3.7%

Camden Ppty Tr generated $13.0M in revenue in fiscal year 2025. This represents an increase of 81.7% from the prior year.

EBITDA
N/A
Net Income
$384.5M
YoY+135.4%
5Y CAGR+25.4%
10Y CAGR+4.4%

Camden Ppty Tr reported $384.5M in net income in fiscal year 2025. This represents an increase of 135.4% from the prior year.

EPS (Diluted)
$3.54
YoY+136.0%
5Y CAGR+23.3%
10Y CAGR+2.5%

Camden Ppty Tr earned $3.54 per diluted share (EPS) in fiscal year 2025. This represents an increase of 136.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$25.2M
YoY+19.8%
5Y CAGR-43.0%
10Y CAGR+9.0%

Camden Ppty Tr held $25.2M in cash against $3.9B in long-term debt as of fiscal year 2025.

Dividends Per Share
$4.20
YoY+1.9%
5Y CAGR+4.8%
10Y CAGR+4.1%

Camden Ppty Tr paid $4.20 per share in dividends in fiscal year 2025. This represents an increase of 1.9% from the prior year.

Shares Outstanding
103M
YoY-3.1%
5Y CAGR+1.2%
10Y CAGR+1.8%

Camden Ppty Tr had 103M shares outstanding in fiscal year 2025. This represents a decrease of 3.1% from the prior year.

Margins & Returns

Gross Margin
-4270.4%
YoY+3459.3pp
5Y CAGR-714.6pp

Camden Ppty Tr's gross margin was -4270.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3459.3 percentage points from the prior year.

Operating Margin
N/A
Net Margin
2964.9%
YoY+677.0pp
5Y CAGR+1817.6pp

Camden Ppty Tr's net profit margin was 2964.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 677.0 percentage points from the prior year.

Return on Equity
8.8%
YoY+5.3pp
5Y CAGR+5.2pp
10Y CAGR-0.0pp

Camden Ppty Tr's ROE was 8.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 5.3 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$270.7M
YoY+441.3%

Camden Ppty Tr spent $270.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 441.3% from the prior year.

Capital Expenditures
N/A

CPT Income Statement

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $2.1M-59.4% $5.3M+105.9% $2.6M-2.6% $2.6M+5.9% $2.5M+61.5% $1.5M-9.8% $1.7M-34.5% $2.6M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $14.7M-25.9% $19.8M+1.2% $19.6M-7.4% $21.2M+13.2% $18.7M+0.2% $18.7M-0.9% $18.8M+3.8% $18.2M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $37.4M+9.6% $34.1M-2.6% $35.0M-1.1% $35.4M+4.7% $33.8M+3.8% $32.6M+0.2% $32.5M+0.8% $32.2M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income $42.4M-72.8% $156.0M+43.2% $108.9M+35.0% $80.7M+107.8% $38.8M-4.6% $40.7M+1067.9% -$4.2M-109.8% $42.9M
EPS (Diluted) $0.40 N/A $1.00+35.1% $0.74+105.6% $0.36 N/A $-0.04-110.0% $0.40

CPT Balance Sheet

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $9.1B+0.2% $9.0B-0.1% $9.1B-0.7% $9.1B+1.4% $9.0B+1.6% $8.9B-1.1% $8.9B-1.5% $9.1B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $40.7M+61.4% $25.2M-2.8% $25.9M-21.6% $33.1M+26.4% $26.2M+24.4% $21.0M-32.6% $31.2M-66.7% $93.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $5.0B+7.6% $4.6B+3.6% $4.4B-0.4% $4.5B+3.6% $4.3B+4.9% $4.1B-0.7% $4.1B-0.5% $4.2B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $4.3B+9.0% $3.9B+4.3% $3.7B-2.2% $3.8B+2.4% $3.7B+7.2% $3.5B+1.0% $3.5B-2.8% $3.6B
Total Equity $4.0B-7.6% $4.4B-3.8% $4.5B-1.1% $4.6B-0.6% $4.6B-1.3% $4.7B-1.4% $4.7B-2.3% $4.9B
Retained Earnings N/A N/A N/A N/A N/A N/A N/A N/A

CPT Cash Flow Statement

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $148.1M-24.7% $196.8M-21.6% $250.9M+8.8% $230.7M+55.6% $148.2M-2.7% $152.4M-41.8% $261.6M+16.2% $225.1M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$20.0M+4.5% -$21.0M-310.6% -$5.1M+97.4% -$197.5M+28.4% -$275.9M-209.4% -$89.2M+6.7% -$95.6M+11.0% -$107.4M
Financing Cash Flow -$35.0M+80.1% -$175.9M+30.5% -$253.1M-858.7% -$26.4M-119.8% $133.3M+281.9% -$73.3M+67.5% -$225.6M-93.2% -$116.7M
Dividends Paid $114.9M-0.5% $115.5M-0.4% $116.0M0.0% $116.0M+2.1% $113.5M0.0% $113.5M0.0% $113.5M0.0% $113.5M
Share Buybacks $262.8M+19.1% $220.7M+341.3% $50.0M $0 $0 $0 $0-100.0% $4.3M

CPT Financial Ratios

Metric Q2'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 1980.8%-973.3pp 2954.1%-1292.8pp 4246.9%+1183.1pp 3063.8%+1502.8pp 1561.0%-1081.3pp 2642.3%+2888.6pp -246.3%-1893.1pp 1646.8%
Return on Equity 1.1%-2.5pp 3.6%+1.2pp 2.4%+0.6pp 1.8%+0.9pp 0.8%-0.0pp 0.9%+1.0pp -0.1%-1.0pp 0.9%
Return on Assets 0.5%-1.3pp 1.7%+0.5pp 1.2%+0.3pp 0.9%+0.5pp 0.4%-0.0pp 0.5%+0.5pp -0.1%-0.5pp 0.5%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 1.05+0.2 0.89+0.1 0.820.0 0.83+0.0 0.81+0.1 0.75+0.0 0.730.0 0.73
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Camden Ppty Tr (CPT) reported $13.0M in total revenue for fiscal year 2025. This represents a 81.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Camden Ppty Tr (CPT) revenue grew by 81.7% year-over-year, from $7.1M to $13.0M in fiscal year 2025.

Yes, Camden Ppty Tr (CPT) reported a net income of $384.5M in fiscal year 2025, with a net profit margin of 2964.9%.

Camden Ppty Tr (CPT) reported diluted earnings per share of $3.54 for fiscal year 2025. This represents a 136.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Camden Ppty Tr (CPT) had $25.2M in cash and equivalents against $3.9B in long-term debt.

Camden Ppty Tr (CPT) had a gross margin of -4270.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Camden Ppty Tr (CPT) had a net profit margin of 2964.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Camden Ppty Tr (CPT) paid $4.20 per share in dividends during fiscal year 2025.

Camden Ppty Tr (CPT) has a return on equity of 8.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Camden Ppty Tr (CPT) generated $826.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Camden Ppty Tr (CPT) had $9.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, Camden Ppty Tr (CPT) spent $270.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Camden Ppty Tr (CPT) had 103M shares outstanding as of fiscal year 2025.

Camden Ppty Tr (CPT) had a debt-to-equity ratio of 0.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Camden Ppty Tr (CPT) had a return on assets of 4.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Camden Ppty Tr (CPT) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Camden Ppty Tr (CPT) has an earnings quality ratio of 2.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Camden Ppty Tr (CPT) scores 35 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top